What we do Zota Health Care Ltd manufactures and markets pharmaceuticals, ayurvedic, nutraceutical, and OTC products, serving chronic illness markets and operating a leading generic retail pharmacy chain. |
Founded in 2,000 |
Market share Largest private-sector generic pharmacy chain in India with over 1582 outlets; exports to 30+ countries. |
Problem solved Provides affordable, high-quality medicines addressing chronic illnesses and increases access to generic drugs domestically and internationally. |
Top clients or who we serve B2C through retail pharmacies, B2B via distributors nationally, and exports to regulated and semi-regulated international markets. |
Key management - |
Our journey and innovations Founded in 2000, expanded from marketing to exports and retail pharmacy chain Davaindia, scaling to 1582 stores by 2025 with continued international approvals. |
Where we operate India (domestic and retail operations) and export markets across Africa, Asia, CIS, and Latin America. |
Top products or what we offer Generic pharmaceuticals, OTC medicines, ayurvedic products, and private-label chronic therapy medicines via retail and exports. |
Top brands Davaindia - India’s largest private generic pharmacy chain; Everyday Herbal under Khadi brand; private-label medicines major revenue driver. |
Raw materials needed Active pharmaceutical ingredients and finished dosage forms sourced from WHO-GMP certified manufacturers. |
Raw materials supplier Recognized WHO-GMP certified domestic and international formulation manufacturers. |
Recurring vs cyclical contribution Majority of revenues are recurring from retail sales and exports with stable demand for chronic therapies. |
Our industry position Key player in Indian generic pharmaceuticals and retail markets; leading retail chain with fast-growing international exports. |
Financial highlights Consolidated revenue Rs 293 Cr in FY25 (62% YoY growth); PAT -Rs 56 Cr due to investments; Davaindia contributed 64% revenue. |
Geographical revenue split Revenue primarily from India (retail and domestic sales) and exports to over 30 countries in regulated and semi-regulated markets. |
Order book - |
Whats driving growth Rapid expansion of Davaindia stores, increased chronic therapy focus, export market penetration, and acquisitions like Everyday Herbal. |
Our future plans Scale Davaindia COCO stores, deepen chronic therapy offerings, complete EU GMP certification, expand export approvals and registrations. |
Our green promise Active CSR focusing on health, education, and environment; policies on governance and sustainability in place. |
Our people and values Board comprising experienced executives and independent directors; focus on ethics, compliance, and employee motivation via ESOPs. |
Key challenges ahead Achieving EU GMP certification, managing costs from rapid expansion, global regulatory compliance, and sustaining profitability amidst investments. |
Interesting facts Davaindia grew from 3 pilot stores in 2017 to 1582 in 2025; largest private generic retail chain in India; acquired Khadi OTC herbal portfolio. |
Risks and strategy Regulatory approvals risk mitigated by diversified markets; focus on proprietary products and franchise model for scalable growth. |
